Crescita Therapeutics Overview

  • Founded
  • 2016

Founded
  • Status
  • Public

  • Employees
  • 69

Employees
  • Stock Symbol
  • CTX

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.45

  • (As of Friday Closing)

Crescita Therapeutics General Information

Description

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Personal Products
Stock Exchange
TSE
Primary Office
  • 2805 Place Louis-R Renaud
  • Laval, Quebec H7V 0A3
  • Canada
+1 (905) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crescita Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.45 $0.48 $0.43 - $0.66 $10M 20.7M 16.6K

Crescita Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 3,485 3,414 1,964 8,958
Revenue 17,387 13,370 11,655 16,828
EBITDA 888 338 1,470 4,002
Net Income (370) (881) 28 1,397
Total Assets 21,570 22,684 21,041 20,545
Total Debt 1,327 2,249 965 1,185
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Crescita Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.

Request a free trial

Crescita Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufact
Drug Discovery
Laval, Canada
69 As of 2021
00.00
000000000 00.00

000000

etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000000
Barcelona, Spain
0000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 00000000
Nashville, TN
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crescita Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Almirall Corporation Barcelona, Spain 0000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Nashville, TN 000 00000 00000000 00000
000-000 0000000000 Private Equity-Backed Ness Ziona, Israel 00 0000 000000000 0000
You’re viewing 3 of 3 competitors. Get the full list »

Crescita Therapeutics Patents

Crescita Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10945952-B2 Rinse-off compositions and uses thereof for delivery of active agents Active 14-Mar-2019 0000000000
CA-3133174-A1 Rinse-off compositions and uses thereof for delivery of active agents Pending 14-Mar-2019 0000000000
US-20200289415-A1 Rinse-off compositions and uses thereof for delivery of active agents Active 14-Mar-2019 0000000000
EP-3937905-A1 Rinse-off compositions and uses thereof for delivery of active agents Pending 14-Mar-2019 00000000
US-20210169800-A1 Rinse-off compositions and uses thereof for delivery of active agents Pending 14-Mar-2019 A61K9/10
To view Crescita Therapeutics’s complete patent history, request access »

Crescita Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Serge Verreault General Manager, Chief Executive Officer & President
Jose DaRocha Chief Financial Officer, Finance
You’re viewing 2 of 5 executive team members. Get the full list »

Crescita Therapeutics Board Members (4)

Name Representing Role Since
0000000 00000000000 Self Board Member 000 0000
000000 00000000 Crescita Therapeutics Chairman & Board Member 000 0000
0000 000000 Self Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Crescita Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crescita Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.

Request a free trial

Crescita Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000 0 01-Sep-2016 0000000000 0000 Pharmaceuticals 00000 000
To view Crescita Therapeutics’s complete acquisitions history, request access »